Impaired plasticity of cortical dendritic spines in P301S tau transgenic mice by unknown
Hoffmann et al. Acta Neuropathologica Communications 2013, 1:82
http://www.actaneurocomms.org/content/1/1/82RESEARCH Open AccessImpaired plasticity of cortical dendritic spines in
P301S tau transgenic mice
Nadine A Hoffmann1,2, Mario M Dorostkar1,2, Sonja Blumenstock2, Michel Goedert3 and Jochen Herms2,4*Abstract
Background: Illuminating the role of the microtubule-associated protein tau in neurodegenerative diseases is of
increasing importance, supported by recent studies establishing novel functions of tau in synaptic signalling and
cytoskeletal organization. In severe dementias like Alzheimer’s disease (AD), synaptic failure and cognitive decline
correlate best with the grade of tau-pathology. To address synaptic alterations in tauopathies, we analyzed the
effects of mutant tau expression on excitatory postsynapses in vivo.
Results: Here we followed the fate of single dendritic spines in the neocortex of a tauopathy mouse model,
expressing human P301S mutated tau, for a period of two weeks. We observed a continuous decrease in spine
density during disease progression, which we could ascribe to a diminished fraction of gained spines. Remaining
spines were enlarged and elongated, thus providing evidence for morphological reorganization in compensation
for synaptic dysfunction. Remarkably, loss of dendritic spines in cortical pyramidal neurons occurred in the
absence of neurofibrillary tangles (NFTs). Therefore, we consider prefibrillar tau species as causative for the
observed impairment in spine plasticity.
Conclusions: Dendritic spine plasticity and morphology are altered in layer V cortical neurons of P301S tau
transgenic mice in vivo. This does not coincide with the detection of hyperphosphorylated tau in dendritic spines.
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Intracellular aggregates of the microtubule-associated
protein tau are found in a large number of neurodegenera-
tive diseases, including AD and frontotemporal dementia
and parkinsonism linked to chromosome 17 (FTDP-17)
[1,2]. In these so-called tauopathies, hyperphosphorylation
of tau promotes its detachment from microtubules, result-
ing in tau mislocalization to the somatodendritic compart-
ment, where it forms oligomers, neuropil threads and
NFTs. The pathological mechanisms triggered by abnormal
tau remain largely unknown, especially with regard to syn-
aptic failure. In sporadic AD, tau-pathology precedes de-
position of extracellular amyloid-β and correlates best with
the grade of dementia [3]. Moreover, synaptic dysfunction
is believed to be the primary cause of cognitive decline in
AD and other dementias [4]. Thus, for understanding the* Correspondence: jochen.herms@dzne.de
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stated.pathological mechanisms causing tauopathies, as well as
for the development of therapies, illuminating the effects
of tau on synapses is indispensable.
Recently, Hoover et al. showed that dendritic spines
are the locus of early synaptic malfunction caused by
tau. Thereby, mistargeting of hyperphosphorylated tau
to intact spines mediates synaptic dysfunction independ-
ently of neurodegeneration [5]. This detrimental role of
hyperphosphorylated and misdistributed tau is further
supported by the finding that dendritic tau mediates
amyloid-β toxicity [6] and tau knockout prevents early
lethality and behavioural deficits in an AD mouse model
[7]. Dendritic spines and synaptic pathology in tauopathy
mouse models have also been analyzed by other groups,
obtaining divergent results: rTg4510 mice, transgenic for
human tau with the FTDP-17 mutation P301L, show re-
duced spine density and impaired dendritic complexity
of pyramidal neurons in the cortex, both in the absence
and presence of NFTs [8,9]. Synapse loss in the hippo-
campus before the emergence of fibrillary tangles was
described for a mouse line expressing P301S mutatedral Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited. The Creative Commons Public Domain Dedication
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duced hippocampal spine density was also found in
TauRD/ΔK280 mice, expressing proaggregation mutant
tau [11]. Conversely, an age-dependent increased spine
density in cortical layer III, but no alterations in the
hippocampus were reported for transgenic mice express-
ing human P301L or wildtype tau [12]. In cortical layer
III pyramidal neurons of mice expressing all six human
tau isoforms instead of murine tau, the spine volume de-
creases with advancing age, while spine density stays un-
affected [13]. Since these studies were based on fixed
brain tissue, so far, dendritic spine plasticity has not been
analyzed in a tauopathy mouse model in vivo. Therefore,
alterations in the total number of spines could not be
attributed to changes in spine kinetics.
In this study, we investigated the effects of mutant tau
expression on the structural plasticity of dendritic spines
in P301S Tau mice [14]. They express human tau protein
bearing an FTDP-17 mutation [15] under the control of
the murine thy1-promoter. FTDP-17 patients carrying
this mutation suffer from an early onset, rapidly progres-
sive frontotemporal dementia and parkinsonism in com-
bination with epileptic seizures [16]. Homozygous P301S
Tau mice similarly exhibit severe tau-pathology already
at 5–6 months of age: Abundant intracellular filaments
composed of hyperphosphorylated tau deposit in several
regions of the central nervous system (CNS), especially
the brain stem and spinal cord [14,17-20]. Progressive
neuron loss, accompanied by neuroinflammation, can be
found in cortical layers I/II [21], but early behavioral
abnormalities have been reported well before the onset
of neurodegeneration [22].
By means of long-term two-photon in vivo imaging,
we found a progressive spine loss on apical tuft den-
drites of cortical layer V neurons in 4-month-old P301S
Tau mice. The remaining spines were enlarged in head
volume and increased in length. Immunohistochemical
characterization of the analyzed pyramidal neurons re-
vealed them to be bare of NFTs or hyperphosphorylated
tau. In contrast to other brain regions like hippocampal
CA3 pyramidal neurons, where abundant deposits of
hyperphosphorylated tau can be found in dendritic
spines, these were absent in the cerebral cortex. This
observation is in line with what is seen in the brain tissue
of AD patients [23,24].
Methods
Transgenic mice
For two-photon in vivo imaging, homozygous mice
transgenic for the 383 amino acid isoform of human tau
protein with the familial FTDP-17 mutation P301S [14]
were crossbred with mice of the YFP-H line [25] (obtained
from The Jackson Laboratory, Bar Harbor, ME, USA).
Mice homozygous for tau (P301S Tau x YFP-H mice) wereused in experiments, while mice lacking mutant tau served
as wildtype controls. The mice were exclusively male and
the offspring of the same founder animals. Tau homozy-
gosity was determined by real time PCR. Mice were group
housed under pathogen-free conditions until surgery from
which on they were singly housed. All procedures were
performed in accordance with an animal protocol ap-
proved by the Ludwig Maximilian University of Munich
and the Government of Upper Bavaria (ref. num. 55.2-
1.54-2531-110-06).
Cranial window surgery
A chronic cranial glass window was implanted over the
right hemisphere of the cerebral cortex (Figure 1a), ap-
plying the open skull preparation as previously described
[26,27]: The mice were anesthetized by an intraperitoneal
injection of ketamine/xylazine (130 and 10 μg/g body
weight, respectively). Additionally, anti-inflammatory dexa-
methasone (6 μg/g body weight) was administered intra-
peritoneally and body temperature was maintained by
a heating pad. A circular piece of the skull, 4 mm in
diameter, was removed above the somatosensory cortex
(centered at the right parietal bone, approximately 2 mm
caudal of the bregma and 2.5 mm lateral of the midline),
using a dental drill (Schick-Technikmaster C1; Pluradent;
Offenbach, Germany). To close the craniotomy, a round
coverslip (5 mm in diameter) was glued to the skull using
dental acrylic (Cyano-Veneer fast; Heinrich Schein Dental
Depot, Munich, Germany). A small metal bar, containing
a screw thread, was mounted next to the coverslip to allow
fixation and precise repositioning of the mouse head dur-
ing subsequent imaging sessions. After surgery, mice re-
ceived a subcutaneous analgesic dose of carprophen
(7.5 μg/g body weight Rimadyl; Pfizer, New York, USA).
Long-term two-photon in vivo imaging
To avoid neuroinflammatory responses, in vivo imaging
was performed after a 3 week recovery period. Each im-
aging session lasted for no longer than 60 min during
which mice were anesthetized by an intraperitoneal in-
jection of ketamine/xylazine (130/10 μg/g body weight)
and body temperature was maintained by a heating pad.
YFP was excited by a titanium-sapphire laser (MaiTai,
Spectra-Physics, Darmstadt, Germany) at 880 nm and
the emission was collected using a 500–550 nm band-
pass filter (LSM 5MP, Carl Zeiss MicroImaging GmbH,
Jena, Germany). Less than 50 mW laser power was de-
livered to the tissue to prevent laser-induced phototoxic-
ity. A 20x water-immersion objective (1.0 NA; Carl Zeiss
MicroImaging GmbH) was used to acquire overview
stacks of 425 × 425 × 350 μm3, starting at the brain sur-
face, with 0.41 × 0.41 × 3.00 μm3 xyz-scaling. Subse-
quently, single spiny dendritic elements at a depth of 50–
120 μm of this volume were imaged at high resolution
Figure 1 Decreased dendritic spine density and impaired spine kinetics in P301S Tau mice. a Location of the chronic cranial glass
window, as implanted for long-term in vivo imaging of YFP-expressing neurons. b Example of an isolated, volume rendered layer V neuron in a
425 × 425 × 550 μm3 xyz-stack of the somatosensory cortex. A section of an apical tufted dendrite, stretching in parallel to the brain surface, is
shown in higher magnification (maximum intensity projection; scale bar: 5 μm). c-c’ Dendritic elements in 4-month-old wildtype (c) and P301S
Tau mice (c’) were analyzed by high-resolution two-photon in vivo imaging over a time period of two weeks (d: day). Repetitive imaging allows
discrimination of stable, gained, and lost spines (black, green, and red arrowheads respectively; maximum intensity projections; scale bars: 2 μm).
d Spine density was reduced in P301S Tau mice at the first in vivo imaging session. Presented are means per animal of 8 mice; 61–82 dendrites
per group; 14–22 dendrites per mouse; means ± SD per group in red. e During the following 14 days, the spine density stayed stable in wildtype
mice but further declined in P301S Tau mice. Presented are means ± SEM of 28–41 dendrites in 3–4 mice per group, 8–12 dendrites per mouse;
normalized to the first imaging day. Line, linear fit. p <0.01 (F test of means). f-h In P301S Tau mice, the densities of persistent (f) and lost spines
(g) was not significantly impaired, while the density of gained spines was decreased (h). Presented are means ± SD of 3–4 mice per group; 28–41
dendrites; 8–12 dendrites per mouse. b, c, e, f & g: Unpaired t test; * p < 0.05.
Hoffmann et al. Acta Neuropathologica Communications 2013, 1:82 Page 3 of 11
http://www.actaneurocomms.org/content/1/1/82
Hoffmann et al. Acta Neuropathologica Communications 2013, 1:82 Page 4 of 11
http://www.actaneurocomms.org/content/1/1/82(0.16 × 0.16 × 1.00 μm3 xyz-scaling). To ensure that these
apical tuft dendrites arose from layer V neurons, and ex-
clude YFP-expressing layer II/III neurons, only dendrites
protruding a depth of 350 μm were chosen (Figure 1b). In
subsequent imaging sessions, previously imaged regions
were relocalized and precisely aligned based on the unique
pattern of blood vessels, neuronal cell bodies, and their
processes. Laser intensity was adjusted to keep the emitted
YFP fluorescence stable.
Immunohistochemistry
Brains of 4- and 6-month-old P301S Tau x YFP-H mice
of mixed sex were processed for immunohistochemistry.
Following transcardial perfusion of the mice with phos-
phate buffered saline (PBS) and 4% paraformaldehyde
(PFA) in PBS at 4°C, brains were removed and fixed in
4% PFA in PBS over night at°C. In an attempt to im-
prove tissue preservation for tau detection in dendritic
spines, as described by Kremer et al. (2011), some mice
were alternatively perfused with PBS at 4°C, brains were
removed and hemispheres were fixed over night at 4°C
in either 4% PFA in PBS or in Bouin solution (71.4% sat-
urated picric acid, 23.8% formaldehyde, 4.8% glacial
acidic acid). 100 μm free-floating frontal sections of the
somatosensory cortex were cut on a vibratome (VT1000S,
Leica Microsystems GmbH, Wetzlar, Germany). During all
following steps, the sections were kept on a shaker at room
temperature. To permeabilize the tissue, the sections were
incubated over night in 2% Triton X-100 in PBS.
For AT8-, AT180-, and HT7-stainings, background
signal was reduced using Endogenous Biotin-Blocking
Kit E-21390 (Molecular Probes, Eugene, OR, USA). Sec-
tions were incubated in 10% normal goat serum (NGS),
1% bovine serum albumin (BSA), and 0.1% Triton X-100
in PBS before primary antibody incubation in 5% BSA
and 0.1% Triton X-100 in PBS over night. The following
monoclonal antibodies, conjugated to biotin, were used
in 1:200 dilutions: HT7 recognizing human tau, AT8
recognizing human and murine tau phosphorylated
at S202 and T205, and AT180 recognizing human
and murine tau phosphorylated at T231 and S235 (all
from Thermo Scientific Pierce Protein Research Products,
Rockford, IL, USA). Enzyme-mediated antibody-detection
was performed using TSA™ kit #26 (Invitrogen, Carlsbad,
CA, USA) with HRP-streptavidin (1:200) in 1% BSA in
PBS and Alexa Fluor 647 tyramide (1:200), according to
the manufacturers’ instructions.
For AT100-stainings, non-specific epitopes were blocked
with Casein I-Block (Invitrogen) for 1 hour. AT100
(Thermo Scientific Pierce Protein Research Products),
recognizing human and murine tau phosphorylated at
Alzheimer-specific epitopes S212 and T214, was ap-
plied for 4 hours, diluted 1:200 in PBS. Detection was
performed by incubating the sections with secondaryanti-mouse antibody conjugated to Alexa Fluor 647
(1:200 in PBS; Invitrogen) for 4 hours.
For all stainings, sections were finally washed 5x10 min
with PBS before mounting on glass coverslips using fluor-
escence mounting medium (Dako, Glostrup, Denmark).
Confocal microscopy
Fluorescence images were acquired with a confocal laser
scanning microscope, mounted on an inverted micro-
scope support (LSM 510 and AxioVert 200, Carl Zeiss
MicroImaging GmbH). Alexa Fluor 488 was excited by
an argon laser at 488 nm and emission was collected
using a 500–550 nm bandpass filter. Alexa Fluor 647
was excited by a helium-neon laser at 633 nm and emis-
sion was collected using a 650 nm longpass filter.
For the AT8-YFP-correlation, a 40x oil-immersion ob-
jective (Plan-Apochromat, NA 1.3; Carl Zeiss MicroIma-
ging GmbH) was used to obtain 360 × 360 × 50 μm3
stacks with 0.35 × 0.35 × 2.00 μm3 xyz-scaling. Per ani-
mal 10 stacks of layer V neurons were analyzed.
Image processing and data analysis
Dendritic spine density was determined using ZEN
2011 Light Edition software (version 7.0, Carl Zeiss
MicroImaging GmbH). Images were corrected with a
gamma of 0.45 and spines were counted manually by
scrolling through the z-stacks. In time-series, a den-
dritic spine was defined as the same if its location did
not change within a range of 1 μm along the dendrite.
Since z-scaling was limited to 1 μm, only protrusions em-
anating laterally from the dendritic shaft were analyzed.
For morphological spine analysis, the three-dimensional
in vivo images were deconvolved (AutoQuant, version
X2.0.1, Media Cybernetics, Bethesda, USA) and semi-
automatically remodelled (Imaris 6.1.5, Bitplane, Zurich,
Switzerland). Spine subtypes were identified using the
Imaris XT spine classification module, based on the follow-
ing hierarchical algorithms (adapted from [28]): mushroom
spine: “max_width(head)/min_width(neck) > 1.4 and max_
width(head) > 0.4 μm and min_width(neck) > 0 μm”;
stubby spine: “length(spine)/mean_width(neck) ≤ 3 or
min_width(neck) = 0 μm or > 0.5 μm”; thin spine: length
(spine)/mean_width(neck) > 3.
Analysis was performed blinded in respect to mouse
genotype.
YFP- and / or AT8-positive layer V pyramidal neurons
were counted manually using ZEN 2011 Light Edition
software (version 7.0; Carl Zeiss MicroImaging GmbH).
All data are presented as mean ± SD or ± SEM, as
stated in the figure legends. Statistical differences be-
tween two groups were determined using unpaired t test.
Since spine head volumes had a log-normal distribution,
in this exceptional case the t test was done on log-
transformed data. All other measurements represent
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orem approximate a normal distribution. Therefore, we
used a parametric test. The slope from a linear regression
was tested for statistical difference from zero by F test.
Statistical analysis and graphs were done using Prism soft-
ware (version 5.04, GraphPad Software Inc., La Jolla, CA,
USA). Figures were arranged using Adobe Illustrator CS4
Extended software (version 11.0.2, Adobe Systems, San
Jose, CA, USA).
Results
In order to analyze the effects of cortical tau-pathology
on dendritic spines, we performed long-term two-
photon in vivo imaging of P301S Tau mice (Figure 1a).
The line was crossbred with mice of the YFP-H line,
expressing yellow fluorescent protein in a subset of cor-
tical neurons, i.e. layer II/III and V pyramidal neurons
(Figure 1b). Thus, we were able to follow the fate of in-
dividual dendritic spines in 4-month-old homozygous
P301S Tau mice and age-matched wildtype mice through
a chronic cranial window (Figure 1c-c’).
Decreased cortical spine density in P301S tau mice
The spine densities of apical tuft dendrites of layer V
neurons showed high variance, ranging from 0.24 to
0.60 spines/μm in wildtype mice and 0.20 to 0.60 spines/
μm in P301S Tau mice. Overall, we found a reduction
in the mean spine density of P301S Tau mice by 17%
(0.34 ± 0.04 compared to 0.41 ± 0.01 spines/μm in wild-
type mice, Figure 1d). By relocalizing and repeatedly im-
aging the same dendritic elements every 3–4 days for a
period of two weeks (Figure 1c-c’), we observed further
aggravation of total spine loss in P301S Tau mice during
disease progression: The relative spine density declined
to 0.94 ± 0.15 of the initial value, while remaining un-
changed in wildtype mice (1.01 ± 0.13; Figure 1e).
Tau transgene expression affects spine kinetics
High-resolution, long-term in vivo imaging enables very
detailed analysis of spine kinetics (Figure 1c-c’). By care-
fully following the fate of single spines, the densities of
stable, gained, and lost spines can be determined for
each consecutive imaging session, providing a measure-
ment of synaptic plasticity. We detected no significant
change in the densities of persistent spines (i. e. stable
for at least one week; Figure 1f ) and lost spines (i. e. dis-
appearing from one to the consecutive imaging session;
Figure 1g) in P301S Tau mice. However, while in wild-
type mice the permanent loss and gain of spines was
well-balanced (0.083 ± 0.012 vs. 0.087 ± 0.015 spines/μm,
respectively; Figure 1g-h), the spine turnover in P301S
Tau mice was shifted: The density of gained spines (i. e.
newly emerging from one to the consecutive imaging
session) was reduced (0.058 ± 0.008 spines/μm), comparedto wildtype mice (Figure 1h). Therefore, we could attribute
the constant loss of total spines to a diminished formation
of new spines caused by tau transgene expression.
Homozygous P301S Tau mice show age-dependent
neurodegeneration – especially in the brainstem [14],
but also in superficial cortical layers, where mainly
GABAergic interneurons are affected [21]. In order to
determine whether YFP-expressing cortical neurons get
lost, we followed the fate of layer V neurons’ apical
dendritic trees as well as layer II/III neuronal somata in
4-month-old P301S Tau mice. However, in a time period
of up to 6 weeks we did not detect the disappearance of
any dendritic branches or the loss of a single neuron
(analysis of 199 cells in 5 mice; data not shown).
Morphological spine alterations in P301S tau mice
Since dendritic spine function and morphology are strongly
correlated, we performed three-dimensional reconstruc-
tions of the in vivo imaged dendritic spines to compare
morphological parameters (Figure 2a-a’). Thereby, we
found the spines of P301S Tau mice to be strongly enlarged
in spine head volume (0.15 ± 0.05 μm3 compared to 0.08 ±
0.01 μm3 in wildtype; Figure 2b), accompanied by a smaller
increase in spine length (2.04 ± 0.14 μm compared to
1.69 ± 0.13 μm in wildtype; Figure 2c). Moreover, we classi-
fied the spines according to their length, maximum head
width, mean and minimum neck width into thin, stubby,
and mushroom spines. In P301S Tau mice, the fraction of
thin spines was strongly reduced (15.39 ± 10.43 compared
to 28.23 ± 7.42 spines/μm in wildtype), while we measured
a gain in mushroom spines (58.63 ± 16.96 compared to
39.58 ± 7.92 spines/μm in wildtype). The stubby spine frac-
tion, however, was not significantly changed (Figure 2d).
Cortical spine impairments in the absence of NFTs
In search for the causative pathological process under-
lying the described spine alterations in P301S Tau mice,
we focused on tau-pathology in YFP-expressing cortical
layer V neurons, the apical tufted dendrites of which we
imaged. In the transgenic mice both YFP and the mutant
human tau are expressed in neuronal subsets under the
control of the murine thy1-promoter. Expression pat-
terns of the transgenes can vary nevertheless, depending
on stochastic factors upon transgene insertion. To verify
if the dendrites imaged in vivo belonged to neurons ex-
pressing the human tau transgene, we performed immu-
nohistochemical labelling for human tau on brain slices
(antibody HT7; Figure 3a). Correlating the HT7-staining
with the YFP-expression (Figure 3a’), we found most of
the YFP-positive layer V neurons to show at least weak
somatic HT7 immunoreactivity (Figure 3a”). Despite the
broad expression of both proteins in the neocortex, it is
not possible to verify that all of the analyzed neurons
did express the tau transgene.
Figure 2 Tau transgene expression affects dendritic spine morphology. a-a’ In vivo imaged dendritic spines (a maximum intensity projection) were
reconstructed (a’, 3D wireframe graphics) and classified into mushroom (red), stubby (green), and thin spines (blue) based on morphological parameters
using Imaris software. Scale bar: 2 μm. b-d In P301S Tau mice, the spine head volume was enlarged (b) and the spine length was increased (c), causing a
shift in the fractions of morphological spine classes (d). Presented are means ± SD of 3–4 mice; 130–167 spines on 10 dendrites per group; 32–45 spines
on 2–4 dendrites per mouse. Unpaired t test of log-transformed data (b), unpaired t test (c, d); * p < 0.05.
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pathology with abundant filaments of hyperphosphory-
lated tau in the cerebral cortex already at young ages
[14,21]. Hence, we expected many of the YFP-expressing
layer V neurons to contain pre-tangle or tangle-like tau-Figure 3 YFP-expressing layer V neurons are free of hyperphosphory
HT7, magenta, a) in the somatosensory cortex of a 4-month-old P301S Tau x
tau is marked by an asterix. YFP-expressing layer V pyramidal neurons (green,
image (a”; inset). b-b” Staining of hyperphosphorylated tau (antibody AT8, m
YFP-H mouse revealed only very few YFP-expressing layer V neurons (gree
the fractions of YFP-expressing (YFP+) layer V neurons containing (AT8+) o
6-month-old (d) P301S Tau mice. Presented are means ± SD of 5–6 mice p
show maximum intensity projections of 50 μm z-stacks. Scale bars: 50 μmaggregates. In search for a fluorescent, brain-permeable
dye for in vivo labelling of these tau-deposits, we tested the
amyloid-binding Congo red derivative FSB ((trans,trans)-1-
fluoro-2,5-bis(3-hydroxycarbonyl-4-hydroxy)styrylbenzene)
[29,30], which stains filamentous tau in the spinal cord andlated tau. a-a” Immunohistochemical labeling of human tau (antibody
YFP-H mouse. One cell filled with densely accumulated somatodendritic
a’) bearing the tau transgene show white cytosol labeling on the merged
agenta, b) in the somatosensory cortex of a 4-month-old P301S Tau x
n; b’) to contain AT8-positive tau (white cell in b”). c-d Pie charts of
r lacking (AT8-) AT8-positive hyperphosphorylated tau in 4- (c) and
er group; 1983–2433 cells in 0.32-0.39 mm3 tissue. a-a” and b-b”
; inset: 30 μm.
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and us [19,31,32]. Applying the same method we did, how-
ever, not succeed in labelling any intracellular tau filaments
in the cerebral cortex with FSB, detectable by in vivo im-
aging. Analysis of brain sections from FSB-injected mice
revealed many labelled cells in the brain stem though,
serving as a positive control. To further exclude the pres-
ence of NFTs in superficial cortical layers, we also tested
thioflavin S. This well-established amyloid-binding fluoro-
phore marks NFTs, such as in the brain of the rTg4510
tauopathy mouse model [9,33]. Since fluorescence spectra
of YFP and thioflavin S largely overlap, we used P301S Tau
mice lacking the YFP-transgene to apply thioflavin S ac-
cording to the published protocol [33]. Again, no specific
signal of the dye could be detected. Even 6-month-old
mice, at the stage when the animals die as a conse-
quence of the tau-pathology in the brain stem, were bare
of FSB- or thioflavin S-labelled cells in the accessible cor-
tical regions.
In default of an in vivo dye, we stained brain sections
for hyperphosphorylated tau using the antibody AT8
(Figuire 3b-b”). To our surprise, we found AT8-positive
tau only in a marginal fraction of YFP-expressing layer V
neurons in 4-month-old P301S Tau mice (0.12 ± 0.13%,
i.e. 3 of 2433 YFP + cells were AT8+; furthermore, 19
AT8+ cells did not express YFP (data not shown);
Figure 3c), and even in 6-month-old mice (1.69 ± 2.87%,
i.e. 34 of 1983 YFP + cells were AT8+; furthermore, 146
AT8+ cells did not express YFP (data not shown);
Figure 3d). Hence, we conclude that the neurons im-
aged in vivo most likely did not contain detectable
amounts of somatodendritic hyperphosphorylated tau
nor NFTs which could account for the observed spine
abnormalities.
Immunohistochemical stainings do not reveal tau in
cortical spines
Since there is recent evidence that mislocalization of
hyperphosphorylated tau to dendritic spines leads to
synaptic impairments [5], we next aimed to look for
tau in spines of cortical layer V neurons. Quantita-
tive biochemical methods such as protein-detection in
synaptosome- and PSD-fractions cannot detect alterations
in specific populations of neurons and are therefore un-
able to to distinguish broad systemic effects from more
subtle changes in neuronal subpopulations. Therefore, we
decided to perform immunohistochemical stainings for
tau on fixed brain slices of the cortical region analyzed
in vivo using the phosphorylation-dependent antibodies
AT8, AT100, and AT180 (Figure 4a-f).
We found AT8-positive hyperphosphorylated tau in
the somatodendritic and axonal compartments of several
neurons, as well as in neuritic dystrophies and neuropil
threads, but never in dendritic spines (Figure 4a-c”’). Thesparse labeling with AT100 and AT180 was usually re-
stricted to the soma and the main shaft of the arising
apical dendrite (Figure 4d-e), in a few cases also staining
higher-order distal dendritic branches in a punctate pat-
tern (Figure 4f). Unlike the phospho-tau stains, a large
number of neurons were labelled with the human tau
specific antibody HT7, congruent to the pan-neuronal ex-
pression of the transgene (Figure 3a). Only a few cells,
however, showed neuritic staining and in none of those
dendritic spines were stained.
Also after application of an alternative brain tissue fix-
ation technique using Bouin solution, which is supposed
to improve tau detection [12], (phospho-)tau could not
be observed in cortical dendritic spines. These results
were furthermore affirmed by DAB-stainings of con-
ventional paraffin sections, thus avoiding impairments
of antibody penetration due to section thickness. The
usage of enzyme-mediated antibody detection provides
strong signal enhancement, enabling tau localization
even in very fine structures like axons or thin dendritic
branches (Figure 4c’, c”’). By analyzing YFP-negative
cells (Figure 4c-j), we also excluded detractions of
antibody-binding by the presence of YFP in the post-
synaptic compartment. Yet, when analyzing different
brain regions like hippocampal CA3 (Figure 4g-j), AT8-
positive tau was clearly localized in neuronal spiny protru-
sions (inset Figure 4g). AT100- and AT180-labeling was
again less pronounced (Figure 4h-j), resembling the cortical
staining pattern. These findings hint at distinctive patho-
logical mechanisms, leading to brain region and neuronal
subtype specific tau mislocalization in tauopathies.
Discussion and conclusions
Dendritic spine abnormalities in tauopathy mouse models
The generation of dozens of tau transgenic mouse models
during the past years (reviewed in [34,35]) has facilitated
studying the potential role of tau in neurodegenerative dis-
eases (reviewed in [2,15]). However, with regard to synap-
tic density and dendritic spine morphology, inconsistent
effects of tau on synapses have been described, strongly
depending on the tauopathy model, the stage of the dis-
ease and the brain region analyzed [9,10,12,13]. All these
approaches were performed ex vivo, therefore missing kin-
etic spine data which can only be obtained by in vivo im-
aging as presented in our study.
Dendritic spines are not rigid structures but rather
bear a strong potential for morphological plasticity, thus
enabling neurons to modify their synaptic interconnec-
tions, the correlates of learning and memory [36]. While
the majority of spines is stable, a small fraction is per-
manently retracted or newly formed, even in the adult
brain [20]. Underlying changes in dendritic actin fila-
ments, modifying spine morphology, can occur on time
scales from seconds to hours [37]. Changes in the total
Figure 4 Failure to detect tau in cortical dendritic spines by means of immunohistochemistry. Immunohistochemical labeling of
hyperphosphorylated tau (antibodies AT8, AT100, and AT180) in cortical layer V pyramidal neurons (a-f) and hippocampal CA3 neurons (g-j).
a-a” YFP-expressing neuron, filled with somatodendritic AT8-positive tau. The marked section of the apical dendrite (dashed rectangle in a”) is shown
in higher magnification in b-b”, demonstrating that the protruding YFP-positive dendritic spines (exemplarily marked by arrowheads) are bare of
hyperphosphorylated tau. c Example of a YFP-negative layer V neuron (c’-c”’, magnifications of the regions marked by dashed rectangles),
containing AT8-positive tau in its soma, axon (arrows in c’), basal dendrites (arrowheads in c’), apical dendritic shaft (c”), and higher-order distal
dendritic braches (arrowheads in c”’). An adjacent AT8-positive layer II/III neuron shows a similar punctate pattern of hyperphosphorylated tau in its
dendritic filaments (arrows in c”’), not to be mistaken for emanating spines. AT8-labeling is also found irregularly in the neuropil, for example in
neuritic dystrophies (asterisks in c”’). Different from the cortex, in hippocampal CA3 neurons, AT8-positive hyperphosphorylated tau was frequently
found in spiny protrusions (inset in g, arrows). Images show maximum intensity projections. In c-j, images were inverted for contrast enhancement.
Scale bars: 2 μm (b), 5 μm (c” & insets d, f & g), 10 μm (a, c’, c”’, e, h-j), 20 μm (c, d, f & g).
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therefore result from either a loss of persistent spines, a
diminished fraction of new spines or an enhanced frac-
tion of retracted spines.
We measured a reduced spine density on apical tuft
dendrites of cortical layer V pyramidal neurons in 4-
month-old homozygous P301S Tau mice which further
decreased during the two weeks imaging period. Obtain-
ing kinetic data on single spine level, this was attributed
to a diminished density of gained spines, while the stable
(respectively persistent) and lost spine densities were
largely unaffected compared to wildtype mice. The
remaining spines underwent morphological reorganization:
They were longer and the head volume was strongly en-
larged, thus increasing the mushroom spine fraction at the
cost of the thin spines.
Numerous studies have shown that spine volume is
proportional to the size of the postsynaptic density
and the AMPA (α-amino-3-hydroxy-5-methyl-4-isoxazole
propionic acid) receptor content (reviewed in [38]). Thus,
we propose that the observed spine remodelling displays a
compensatory mechanism for the loss of total spine num-
ber, thereby strengthening the remaining synaptic contacts.
Moreover, the decrease in gained spines is morphologicallyreflected in the diminished fraction of thin spines, which
commonly correspond to non-synaptic transient precur-
sors of the larger established spines [39,40].
Previous studies on tauopathy mouse models have ob-
tained divergent results with regard to dendritic spines:
While in most models, the spine density was found to
be reduced [8-10], in others an increased [12] or un-
changed spine density [13] was observed. Direct compari-
son of the results is hindered by both genetic differences
of the mouse models used as well as specific properties of
the diverse neuronal populations analyzed. However, detri-
mental effects of abnormal tau were found in most stud-
ies, thereby causing a loss of dendritic spines. Our study
adds the important finding that expression of P301S mu-
tant human tau impairs spine turnover and morphology,
leading to a net loss of spines, accompanied by structural
reorganization.
Mislocalization of hyperphosphorylated tau to spines
It was reported recently that tau localization to dendritic
spines mediates synaptic dysfunction in FTDP-17 and
AD mouse models [5,6]. This was shown mainly by ana-
lyzing cultured hippocampal neurons of mice expressing
P301L mutated, truncated, or wildtype human tau (lines
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aptic accumulations of hyperphosphorylated tau in the
hippocampus have also been shown for other tau trans-
genic mice (lines Tet-hTauP301L, 3xTg-AD, and PS19)
by means of electron microscopy [10,41,42]. Moreover, tau
was found to be associated to PSD95 in forebrain extracts
of rTg4510 and rTg21221 mice [40] and present in a few
dendritic spines of cortical neurons in rTg4510 mice [8].
When we investigated brain slices of P301S Tau mice
utilizing immunohistochemistry, hyperphosphorylated
tau could also clearly be located in dendritic spiny pro-
trusions of CA3 hippocampal neurons. However, we
never detected tau in dendritic spines of pyramidal neu-
rons in the cortical regions accessible for in vivo imaging.
The protein was even absent from spines of neurons in
which the somatodendritic compartment was almost com-
pletely filled with filamentous hyperphosphorylated tau.
The brain region specific mislocalization of hyperpho-
sphorylated tau to dendritic spines in the tauopathy
mouse model analyzed here is supported by very similar
findings in AD patients. There, only the thorny excres-
cences of CA3 hippocampal neurons contain hyperpho-
sphorylated tau, but not dendritic spines in other fields
of the hippocampal formation or the adjacent cortex
[23,24]. Unlike dendritic spines of cortical pyramidal
neurons, which have an actin-based cytoskeleton, the
CA3 thorny excrescences occasionally contain microtu-
bules [43,44]. This explains the presence of microtubule-
associated proteins like tau inside the spiny protrusions.
In conclusion, we suggest different mechanisms under-
lying synaptic impairment in tauopathies, depending on
specific characteristics of the affected neuronal popu-
lations. Moreover, these accumulations of hyperpho-
sphorylated tau in hippocampal postsynapses could
also cause dysfunctions of the local or further inter-
connected neuronal networks. Thus, impaired hippocam-
pal signaling might contribute indirectly to cortical spine
pathology.
Axonal pathology and local network dysfunction causing
spine impairments
Methodical restrictions make it nearly impossible to syn-
chronously follow the fate of single dendritic spines and
their presynaptic counterparts (i. e. axonal boutons)
in vivo. Hence, with our kinetic data we cannot clarify if
the loss of spines is a primary or secondary event,
caused by axonal pathology which is known to be very
prominent in tauopathies [45-47]. Given the lack of tau
transgene expression in a fraction of YFP-positive layer
V neurons makes it even more likely that presynaptic fail-
ure partially accounts for the dendritic spine impairments.
Moreover, a severe neuron loss in superficial cortical
layers, mainly affecting GABAergic interneurons, was re-
ported for homozygous P301S Tau mice already at theage of 3 months [21]. Since those inhibitory interneu-
rons also form connections with pyramidal cells [48], a
decline in inhibition might lead to a compensatory re-
duction of excitatory synapses. Neurodegeneration in
P301S Tau mice, which could only partially be correlated
to intracellular tau-deposits, is also accompanied by in-
flammatory responses [17]. Microglia and astrocytes are
known to be critically involved in healthy brain homeo-
stasis and synaptic maintenance [49-51]. Therefore, the
induction of inflammatory processes can have significant
implications on dendritic spine plasticity, thus prevent-
ing the emergence of new spines or causing morpho-
logical alterations. Summarized, the observed changes in
dendritic spines might be an indirect effect, caused by
axonal pathology or local network dysfunction.
In search for the toxic tau species
We demonstrated in this study, that dendritic spine loss
and remodelling in cortical neurons of P301S Tau mice
occur in the absence of hyperphosphorylated tau accu-
mulation. This is in line with other studies showing that
tau-aggregates and even NFTs are not sufficient to cause
cognitive decline or neurodegeneration: In a reversible
tauopathy mouse model, memory function recovered
after tau transgene suppression despite continuing NFT
build-up [52]. Furthermore, structural and functional
neuronal changes in different tauopathy mice are inde-
pendent of the presence of NFTs [9,10], and accumula-
tion of insoluble tau does not necessarily affect spine
density and morphology [53]. On the other hand, there
is strong evidence for the existence of neurotoxic prefi-
brillar tau dimers and higher order oligomeric aggregates
in tauopathies such as AD [54-56]. Also, a dendritic
function of tau monomers was suggested to mediate
excitotoxicity in AD mouse models [6]. Therefore, we
argue for prefibrillar tau as the toxic species in tau-
dependent neurodegenerative diseases. Further studies
will be needed to clarify the specific pathogenic mechan-
ism and to finally find ways of disease prevention, arrest,
or even cure.
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